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Mast cell were initially studied mostly for their implication in type 
I hypersensitivity and allergies (Blank and Rivera, 2004; Galli et al., 
2008b). However, research over the last 20 years has made clear that 
they do more than just causing a runny nose or asthma attacks. In 
fact, they have emerged as prime actors of immune and inflamma-
tory responses. As such they sense their environment via numer-
ous cell surface expressed receptors to orchestrate an appropriate 
immune and inflammatory response. Work from many laboratories 
has made clear that mast cells participate in the restoration of tissue 
homeostasis following an offensive event contributing for example 
to the elimination of infectious agents as well as to tissue repair 
and remodeling responses (Marshall, 2004; Galli et al., 2005; Blank 
et al., 2007; Abraham and St John, 2010; Beghdadi et al., 2011).
Mast cells are tissue-localized effectors of hematopoietic origin. 
They are particularly prominent in tissues that are in contact with 
the external environment such as the skin, the gastrointestinal tract, 
or the airways. Yet, they are present also in many other tissues of an 
organism and often their numbers increase upon an inflammatory 
reaction. They can be found at strategic locations close to blood 
capillaries in order to rapidly communicate to other hematopoi-
etic effectors to enter into action. They are also found in contact 
with nerve terminals allowing these cells, via released mediators, 
to communicate to the brain the presence of environmental dan-
gers or reversely to respond to signals emanating from the brain, 
thus providing a relay between the central nervous system and the 
immune system (Theoharides et al., 2012).
One of the prime characteristics of mast cells is to release rapidly 
within a few minutes upon activation a whole set of inflammatory 
products by cellular degranulation (Figure 1) including histamine 
and proteases, proteoglycans, lysosomal enzymes, etc. (Blank and 
Rivera, 2004). As a consequence, blood vessels dilate thus increasing 
the blood flow in the offended area. Moreover, under the effect of 
released histamine, vessels become permeable allowing the influx of 
other inflammatory cells and other inflammatory products (such 
as for example immunoglobulins and complement) into tissues 
to mount an inflammatory response against the insult. In a more 
delayed response mast cells also produce lipid mediators such as 
prostaglandins and leukotrienes, which enhance some of the ini-
tial tissue responses and promote supplementary responses such 
as increased temperature (fever), smooth muscle contraction, etc. 
This is followed by a third wave of mediators, which correspond to 
various cytokines and chemokines allowing to enhance the flow of 
other inflammatory and immune cells into tissue, but also to start 
to regulate and coordinate this inflammatory response. Interestingly, 
the array of mediators released may differ depending on the type of 
stimulus. Thus, stimulation of Toll-like receptor 4 (TLR4) by bacte-
rial products such as LPS usually does not promote the first wave 
of degranulation, but rather leads to an enhanced production of 
cytokines and chemokines (Leal-Berumen et al., 1994). Therefore, 
in addition to releasing a whole set of inflammatory mediators, mast 
cells can initiate different actions allowing these cells to fine-tune the 
inflammatory response. Indeed, evidence has emerged that mast cells, 
depending on the type of stimulus initiate different actions that can 
have opposite pro- or anti-inflammatory consequences (Metz et al., 
2007; Galli et al., 2008a; Beghdadi et al., 2011). Interestingly, in some 
cases this may depend on the strength of the stimulus or on its timing 
in the course of an inflammatory reaction (Beghdadi et al., 2011).
While in the past many reviews have focused on the capacity of 
these cells to respond to IgE-mediated activation, the focus of this 
ebook of Frontiers in Innate Immunology is devoted substantially to 
emphasize other types of stimuli for mast cells and the molecular 
mechanisms involved, as well as to highlight new types of responses 
by these cells. Thus, several reviews of this ebook describe new types 
of stimuli for these cells involving chemokines (Halova et al., 2012), 
sex hormones (Zierau et al., 2012), tetraspanins (Koberle et al., 2012), 
TRP channels (Freichel et al., 2012), TLRs (Sandig and Bulfone-Paus, 
2012). Another article provides a general description of novel identi-
fied receptors (Migalovich-Sheikhet et al., 2012) that may act also as 
inhibitory receptors of an inflammatory reaction. Some contributions 
deal with the regulation of mast cell activation involving for example 
cytoskeletal elements (Draber et al., 2012), ion channels or tetraspa-
nins (Freichel et al., 2012; Koberle et al., 2012), or the mechanism 
Figure 1 | May–grünwald/giemsa stain of a resting human intestinal 
mast cell and a mast cell following activation induced degranulation. 
Note the increase in size and loss of granule staining (Figure from Lorentz 
et al., 2012).
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involved in secretory granule fusion or the crosstalk between different 
cell surface receptors (Lorentz et al., 2012; Migalovich-Sheikhet et al., 
2012). Another point discussed is the implication of these stimuli 
in new types of biological responses mediated by mast cells. This 
includes for example a description of how female sex hormones can 
influence allergic asthma, how these hormones participate in mast 
cell uterine functions (Zierau et al., 2012) and how mast cells can 
interfere with reproductive processes (Woidacki et al., 2013). Another 
chapter analyses the interaction of mast cells with other immune cells 
discussing the receptors and mediators involved in these new types 
of connections (Gri et al., 2012).
Thus, while in the past mast cells have been often discussed 
with respect to their participation in allergic type of responses this 
collection of specific chapters aims to stress that these cells are in 
fact versatile inflammatory effectors with multiple functions in the 
organism. Indeed, cells resembling mast cells that contain histamine 
and proteoglycans such as heparin have already been recognized 
in tunicates (Cavalcante et al., 2002), which are amongst the first 
multicellular organism preceding vertebrates. This is well before the 
appearance of IgE, making clear that these cells probably are part 
of an ancient immune surveillance system allowing the organism 
to defend itself against tissue damage and organize physiological 
responses within tissues.
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